Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8438393 | EBioMedicine | 2017 | 6 Pages |
Abstract
PD-L1 expression may serve as a useful biomarker in predicting invasiveness of EFVPTC and distinguishing NIFTP from invasive EFVPTC. To our knowledge this is the first report suggesting the application of a protein biomarker to confirm NIFTP as benign indolent neoplasms.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Guodong Fu, Olena Polyakova, Christina MacMillan, Ranju Ralhan, Paul G. Walfish,